drugset / Trial / NCT03195270

Use of PET/MR Imaging in Chronic Pain

NCT03195270

Phase 1 Completed 88 enrolled Stanford University GE Healthcare · collab
NaSingle-groupOpen-labelDiagnostic

Summary

The investigators are studying the ability of PET/MR imaging (using the PET tracer \[18F\]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.

Timeline

Start
2014-11-24
Primary completion
2022-01-20
Completion
2022-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FDG Diagnostic / imaging agent 370 mbq Intravenous

Indications